2020 ISPE Continuous Manufacturing Virtual Workshop

Features
Continuous manufacturing has attracted significant interest over the past decade for small molecules formulated as drug products. The case for adopting continuous manufacturing platforms for manufacturing biologics (i.e., large proteins or biologic products such as vaccines) would, in principle, be...
iSpeak Blog
When we first launched the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) in 2017, we benefited from an incredible enthusiasm and engagement from across the ecosystem. At the time, academic institutions were working to...
iSpeak Blog
It’s hard to believe, but it was 10 years ago when I gave my first presentation on continuous manufacturing for pharmaceuticals. It was at the ISPE Nordic Conference in Copenhagen in 2010, and I was still at FDA at the time. Looking back, it’s...